London-based personalised nutrition startup Zoe has received a $2.5 million investment from recent VC world entry Flight Fund. According to the company, the additional capital will be used to further scale operations.
Putting the commercial play aside for a moment, Zoe is fusing tech with collaborations with leading scientists around the world, resulting in the ongoing PREDICT programme, a global nutritional research initiative, and an 800,000-person observational study to measure the accuracy of its AI diagnostic for COVID-19.
Based on results uncovered in the PREDICT programme, Zoe’s personalised nutrition offer begins with at-home tests that analyse blood sugar, blood fat responses, and the gut microbiome.
Combining these results with artificial intelligence and the data from thousands of participants the PREDICT studies, Zoe then generates personalised scores for any food an individual eats. Members are then presented with tools to build daily habits via in-app tools, lessons and nutritional support, all geared towards assisting them in eating the best possible foods for their bodies and their health goals.
Although the company and its co-founder George Hadjigeorgiou call London home, the service is yet available on UK shores, but is expected to launch later in 2023. According to the company:
"We opted to bring the ZOE programme to the UK as soon as we possibly could, which means that some of the digital experience will still appear in American English and the database of foods isn’t as comprehensive as we’d like yet.
Our early access members in the UK will get access to ZOE’s cutting-edge at-home testing kit and the ZOE app. These first members will be asked for feedback about their experience to help ZOE get the programme ready for general release in the UK."
In addition to the new cap table participant, Zoe is backed by Balderton Capital, Ahren Innovation Capital, Daphni, L Catterton, Accomplice, Transformational Healthcare, Errol Damelin, Tim Kendall, Osi Umenyiora, and Eli Manning.